Spectrum Pharmaceuticals reported $0 in Stock for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Amgen AMGN:US $ 4152M 37M
Astellas Pharma 4503:JP Y 148732M 8522M
Bayer BAYN:GR € 10644M 519M
Biogen BIIB:US $ 1347.9M 93.1M
Bristol Myers Squibb BMY:US $ 2163M 26M
Coherus Biosciences CHRS:US $ 37.58M 58.5M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Endo International Ordinary Shares ENDP:US $ 297.3M 41.15M
GlaxoSmithKline GSK:LN 6244M 86M
Karyopharm Therapeutics KPTI:US $ 3.94M 38K
Novartis NOVN:VX SF 6885M 226M
Puma Biotechnology PBYI:US $ 7.21M 0.41M
Seattle Genetics SGEN:US $ 181.38M 18.19M
Takeda 4502:JP Y 783476M 4328M
Teva Pharmaceutical TEVA:IT 4.17B 195M
YTE INCY:US $ 21.3M 4.63M